Roman Laszlo, Mareike Schwiebert, Karen Anna Menzel, Christian Eick, Birgit Schreiner, Juergen Schreieck
Purpose: Atrial fibrillation (AF) results in tachycardia-induced ionic remodeling. Pharmacological prevention of tachycardia-induced ionic remodeling not only with “classical†antiarrhythmics but also with drugs which provide a basis for some of the pillars of the so-called “upstream†therapy of AF like corticosteroids or statins has been proposed as a therapeutic strategy.